vasopressin v1

Terlipressin Acetate, a highly selective vasopressin V1 receptor agonist, on oxygen and glucose deprivation re-oxygenation (OGD R)-induced damage in intestinal epithelial cells (IEC-6).Terlipressin acetate exerts anti-inflammatory and anti-oxidative effects. Terlipressin acetate has the potential for hepatorenal syndrome and norepinephrine-resistant septic shock research.

Vasopressin acetate is a peptide hormone with vasoconstrictive and antidiuretic activities that binds to the vascular arginine vasopressin receptor, V1, with Kd values of 1.31 and 1.44 nM in A7r5 rat aortic smooth muscle cells and neonatal rat cardiomyocy

(Phe2,Orn8)-Oxytocin, a selective V1 vasopressin agonist, exhibits sustained contractility in rabbit epididymis, achieving an EC50 value of 280 nM [1].

(Phe2,Orn8)-Oxytocin acetate, a selective V1 vasopressin agonist, demonstrates pronounced contractility induction in rabbit epididymis, characterized by a sustained response with an EC50 value of 280 nM [1].

(Phenylac1,D-Tyr(Et)2,Lys6,Arg8,des-Gly9)-Vasopressin, a potent vasopressin V1 receptor (VP V1R) antagonist, significantly lowers mean arterial pressure (MAP) in rats [1].